Search results

117 items matching your search terms.
Filter the results.
Item type

New items since

Sort by relevance · date (newest first) · alphabetically
Immune cells in the gut may improve control of HIV growth
A new study may help clarify why some people infected with HIV are better able to control the virus. It may also pinpoint a target for treatment during early HIV infection aimed at increasing the supply of certain immune cells in the gut.
Located in News / 2012 / June
HIV hides soon after infection, UNC research shows
A team of researchers led by the University of North Carolina School of Medicine has demonstrated that latency develops soon after infection and slows when antiretroviral therapy is given.
Located in News / 2012 / May
Longer breastfeeding along with antiretroviral drugs could lower HIV transmission to babies
New research finds that early weaning – stopping breastfeeding before six months – is of little, if any, protective value against HIV transmission nor is it safe for infant survival.
Located in News / 2012 / April
UNC professor Myron Cohen wins top award from Clinical Research Forum for HIV prevention study
Cohen’s study, HIV Prevention Trials Network 052, showed that treating people with HIV with antiretroviral therapy renders them virtually non-contagious, reducing sexual transmission by 96 percent.
Located in News / 2012 / April
Triangle Business Journal names Cohen, Zanation, Sharpless "Health Care Heroes"
Dr. Myron Cohen won the Lifetime Achievement Award, Dr. Norman Sharpless, the Innovator/Researcher award, and Dr. Adam Zanation the "Rising Star" award.
Located in Vital Signs / 2012 / April 5
Cohen profiled by Science magazine
Learn more about the HPTN study, called the "Breakthrough of the Year," in this Q&A about the the process of discovery with Dr. Mike Cohen, Director of the UNC Institute for Global Health and Infectious Diseases.
Located in Vital Signs / 2012 / April 5
Hematologic malignancies rapidly increasing and unaddressed in sub-Saharan Africa
UNC-led team offers clinical, research agenda
Located in News / 2012 / April
Drug helps purge hidden HIV virus, study shows
This study is the first to demonstrate that the biological mechanism that keeps the HIV virus hidden and unreachable by current antiviral therapies can be targeted and interrupted in humans, providing new hope for a strategy to eradicate HIV completely.
Located in News / 2012 / March
UNC HIV prevention research named scientific breakthrough of the year
The HIV Prevention Trials Network 052 study, led by Myron S. Cohen, MD of the University of North Carolina at Chapel Hill, has been named the 2011 Breakthrough of the Year by the journal Science.
Located in News / 2011 / December
When prophecy fails: How to better predict success in HIV prevention clinical trials
New research from the University of North Carolina at Chapel Hill schools of medicine and pharmacy may help explain the failure of some recent clinical trials of prevention of HIV infection, compared to the success of others that used the same drugs.
Located in News / 2011 / December